Don't miss the extraordinary opportunity to attend the 2nd annual meeting of the International Society of Pharmacogenomics (ISP), a joint meeting with the Pacific Rim Association for Clinical Pharmacogenetics (PRACPG). Join the experts at the beautiful Biltmore Hotel in downtown Los Angeles for two days of rich presentation and knowledge-sharing.

This meeting is a satellite of the 53rd Annual Meeting of the American Society of Human Genetics (ASHG), occurring November 4-8, 2003.

Guest speakers will include:

• Junichi Azuma (Osaka University, Japan)
• Francis Collins (Director, National Human Genome Research Institute, NIH)
• David Flockhart (Indiana University)
• Magnus Ingleman-Sundberg (Karolinska Institute, Stokholm, Sweden)
• Ronald Krauss (Lawrence Berkeley National Laboratory)
• Urs A. Meyer (University of Basel, Switzerland)
• Gerard Siest (University of Nancy, France)
• Kari Stefansson (President and CEO deCode Genetics, Reykjavik, Iceland)
• Richard Weinshilboum (Mayo Clinic)
• John Weinstein (National Cancer Institute, NIH)

For detailed information, the complete program of events, and registration, please visit:

www.pharmacogenomics.org.uk

We will have a poster session for emerging research results. Please consider submitting your own abstract for review and consideration at: www.pharmacogenomics.org.uk/abstract1.asp

'"/>

Contact: Tonya Heiland
theiland@mednet.ucla.edu
310-825-7875
Molecular Psychiatry
18-Sep-2003

Page: 1
Related biology news :

1. Hot topics at XVI INQUA Congress
2. Hearing loss & rehab, stroke & depression among topics of Vol. 39, Iss 5, JRRD
3. Cloning pigs and drug discovery among hot topics
4. Spinal cord injury and Alzheimers risk among topics at American Chemical Society meeting
5. Spinal cord injury and Alzheimers risk among topics at American Chemical Society meeting
6. Cancer, bio-engineering, AIDS among topics at Biotech 2001 conference
7. Ag Biotech and E-Commerce hot topics at ASTA Annual Convention
8. Most Americans open to pharmacogenomics research
9. Pioneer in role and uses of SNPs in pharmaceutical development to present at the IBC pharmacogenomics, SNPs & genetics patenting conference